Russia’s focus on domestic pharma production could shield it from sanctions’ effects
Russia’s pharma manufacturing is more focused on the domestic market due to its comparative lack of FDA and EMA approvals.
By
Comment
Latest in
Comment
Top tweets: CDC’s concern over UK’s Monkeypox outbreak and more
Pharmaceutical Technology lists five of the most popular tweets on infectious diseases in May 2022 based on data from GlobalData’…
The Metaverse: Regulatory trends
The metaverse will make digital media experiences more immersive, inclusive, and accessible than today. However, it will raise social concerns…
Non-stop investment from CMOs and US Government into continuous manufacturing
CMOs have been increasingly adopting the use of continuous manufacturing for biologics production following FDA approval.
By
The Metaverse: Macroeconomic trends
Gaming and social media companies are at the vanguard of metaverse development, but enterprises will lead the charge in the…
The Metaverse: Technology trends
The metaverse brings together a range of next-generation technologies from cloud computing to artificial intelligence (AI), blockchain, cryptocurrencies, cybersecurity, the…
Ashvattha’s new self-administered anti-VEGF therapy may address unmet needs for DME
Ashvattha Therapeutics’ D-4517.2 stands out among anti-VEGF treatments in that it can be self-administered using an autoinjector.
By
Lilly announces results from SURPASS programme for T2D and obesity therapy Mounjaro
Further trials for pediatric and heart failure patients are currently ongoing.
By